AXSM earnings

Catalyst

AXSM earnings

AXSM earnings — 2026-08-10

Axsome Therapeutics furnished its earnings release to the SEC on August 10, 2026 (8-K, Item 2.02) and filed its 10-Q for the quarter ended June 30, 2026 the same day. Its 10-Q reports (GAAP): revenue $218M, diluted EPS -$0.99, net income -$51M.

Sources

10 events